Zhejiang Hengtong Hits Day High with Strong 3.86% Intraday Surge

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 3.86% on May 26, 2026. The stock reached an intraday high of CNY 6.79, reflecting its strong performance relative to the broader market. Over the past week, Zhejiang Hengtong has surged by 15.83%, and its one-month performance stands at an impressive 29.17%. Year-to-date, the stock has increased by 26.27%, significantly outperforming the China Shanghai Composite, which has only seen a 4.45% rise during the same period. In terms of long-term performance, the stock has demonstrated a remarkable 139.5% increase over the past year and a substantial 166.01% rise over the last three years. However, it is important to note that the company has faced challenges, including a high debt-equity ratio of 8.99% and rising raw material costs. Despite these factors, the stock's current valuation metrics, including a price-to-book ratio of 4.74 and a return on equity of 4.13%, indicate a complex financial landscape for investors to consider.